BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 8126164)

  • 1. Development of a recombinant enzyme-linked immunosorbent assay for detection of antibodies against Epstein-Barr virus nuclear antigens 2A and 2B.
    Geertsen R; Espander-Jansson A; Dobec M; Price P; Wunderli W; Rymo L
    J Clin Microbiol; 1994 Jan; 32(1):112-20. PubMed ID: 8126164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of Epstein-Barr virus nuclear antigen 1,2A and 2B in the baculovirus expression system: serological evaluation of human antibodies to these proteins.
    Hille A; Klein K; Bäumler S; Grässer FA; Mueller-Lantzsch N
    J Med Virol; 1993 Mar; 39(3):233-41. PubMed ID: 8385705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune response to different sequences of the EBNA I molecule in Epstein-Barr virus-related disorders and in autoimmune diseases.
    Marchini B; Dolcher MP; Sabbatini A; Klein G; Migliorini P
    J Autoimmun; 1994 Apr; 7(2):179-91. PubMed ID: 7518683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibodies against Epstein-Barr nuclear antigen (EBNA) in multiple sclerosis CSF, and two pentapeptide sequence identities between EBNA and myelin basic protein.
    Bray PF; Luka J; Bray PF; Culp KW; Schlight JP
    Neurology; 1992 Sep; 42(9):1798-804. PubMed ID: 1381067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of enzyme-linked immunosorbent assays with chimeric fusion proteins to titrate antibodies against Epstein-Barr virus nuclear antigen 1.
    Inoue N; Kuranari J; Harada S; Nakajima H; Ohbayashi M; Nakamura Y; Miyasaka N; Ezawa K; Ban F; Yanagi K
    J Clin Microbiol; 1992 Jun; 30(6):1442-8. PubMed ID: 1320628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinction between Epstein-Barr virus type A (EBNA 2A) and type B (EBNA 2B) isolates extends to the EBNA 3 family of nuclear proteins.
    Rowe M; Young LS; Cadwallader K; Petti L; Kieff E; Rickinson AB
    J Virol; 1989 Mar; 63(3):1031-9. PubMed ID: 2536817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthetic peptides deduced from the amino acid sequence of Epstein-Barr virus nuclear antigen 6 (EBNA 6): antigenic properties, production of monoreactive reagents, and analysis of antibody responses in man.
    Falk K; Linde A; Johnson D; Lennette E; Ernberg I; Lundkvist A
    J Med Virol; 1995 Aug; 46(4):349-57. PubMed ID: 7595412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-Epstein-Barr virus-nuclear antigen-1, -2A and -2B antibodies in rheumatoid arthritis patients and their relatives.
    Youinou P; Buisson M; Berthelot JM; Jamin C; Le Goff P; Genoulaz O; Lamour A; Lydyard PM; Seigneurin JM
    Autoimmunity; 1992; 13(3):225-31. PubMed ID: 1335296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Evaluation of IgG-IgM antibodies against the Epstein-Barr virus nuclear antigen (EBNA-1) using ELISA].
    Martínez Zapico R; Sobejano L; Llamazares I; Ladrón de Guevara C
    Enferm Infecc Microbiol Clin; 1992 May; 10(5):281-3. PubMed ID: 1327168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoantibodies from patients with systemic lupus erythematosus bind a shared sequence of SmD and Epstein-Barr virus-encoded nuclear antigen EBNA I.
    Sabbatini A; Bombardieri S; Migliorini P
    Eur J Immunol; 1993 May; 23(5):1146-52. PubMed ID: 8386666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of an Epstein-Barr virus nuclear antigen 2 variant (EBNA 2B) by specific sera.
    Sauter M; Mueller-Lantzsch N
    Virus Res; 1987 Aug; 8(2):141-52. PubMed ID: 2823499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carboxyl-terminal domain of the Epstein-Barr virus nuclear antigen is highly immunogenic in man.
    Milman G; Scott AL; Cho MS; Hartman SC; Ades DK; Hayward GS; Ki PF; August JT; Hayward SD
    Proc Natl Acad Sci U S A; 1985 Sep; 82(18):6300-4. PubMed ID: 2412231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human cytotoxic T-cell responses against Epstein-Barr virus nuclear antigens demonstrated by using recombinant vaccinia viruses.
    Murray RJ; Kurilla MG; Griffin HM; Brooks JM; Mackett M; Arrand JR; Rowe M; Burrows SR; Moss DJ; Kieff E
    Proc Natl Acad Sci U S A; 1990 Apr; 87(8):2906-10. PubMed ID: 2158098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening for nasopharyngeal carcinoma with an ELISA using the Epstein-Barr virus nuclear antigen, EBNA 1: a complementary test to the IgA/VCA immunofluorescence assay.
    Cheng HM; Foong YT; Mathew A; Sam CK; Dillner J; Prasad U
    J Virol Methods; 1993 Apr; 42(1):45-51. PubMed ID: 7686558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epstein-Barr virus gene expression in nasopharyngeal carcinoma.
    Young LS; Dawson CW; Clark D; Rupani H; Busson P; Tursz T; Johnson A; Rickinson AB
    J Gen Virol; 1988 May; 69 ( Pt 5)():1051-65. PubMed ID: 2836550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epstein-Barr virus (EBV) antigen-specific leukocyte migration inhibition in infectious mononucleosis. II. Kinetics of sensitization against five EBV-encoded nuclear proteins and the latent membrane protein.
    Szigeti R; Kallin B; Dillner J; Henle G; Henle W; Lerner RA; Rymo L; Timar L; Klein G
    Clin Immunol Immunopathol; 1989 Jun; 51(3):396-405. PubMed ID: 2470542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antigenic and sequence variation in the C-terminal unique domain of the Epstein-Barr virus nuclear antigen EBNA-1.
    Wrightham MN; Stewart JP; Janjua NJ; Pepper SD; Sample C; Rooney CM; Arrand JR
    Virology; 1995 Apr; 208(2):521-30. PubMed ID: 7538250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum and salivary IgA antibodies against a defined epitope of the Epstein-Barr virus nuclear antigen (EBNA) are elevated in nasopharyngeal carcinoma.
    Foong YT; Cheng HM; Sam CK; Dillner J; Hinderer W; Prasad U
    Int J Cancer; 1990 Jun; 45(6):1061-4. PubMed ID: 1693600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of antibodies to Epstein-Barr virus antigens by enzyme-linked immunosorbent assay.
    Hopkins RF; Witmer TJ; Neubauer RH; Rabin H
    J Infect Dis; 1982 Dec; 146(6):734-40. PubMed ID: 6183369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of antibody titers to Epstein-Barr virus nuclear antigens in sera of patients with Sjögren's syndrome and with rheumatoid arthritis.
    Inoue N; Harada S; Miyasaka N; Oya A; Yanagi K
    J Infect Dis; 1991 Jul; 164(1):22-8. PubMed ID: 1647426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.